EGFR and breast carcinoma: In vitro studies have demonstrated that treating breast cancer and pancreatic cancer cells with high glucose results in molecular changes such as phosphorylation of the epidermal growth factor receptor (EGFR), which promotes cancer cell proliferation [15,16].